A majority (324/581; 56%) of FR-20 enhancer sites in Fujioka cells overlapped with sites of colocalized FOXC1 and RUNX1 binding in BB171 AML cells; 459/1,096 (42%) sites overlapped in the opposite comparison. Here, FOXC1 is linked to acute myeloid leukemia.